'김갑성' 기자의 전체기사
-
마이크로밴 인터내셔널, 신임 사장으로 셔먼 맥밀런 임명
헌터스빌, 노스캐롤라이나, 2025년 10월 16일 -- 항균 및 악취 방지 솔루션 분야의 글로벌 선도 기업 마이크로밴 인터내셔널(Microban International)이 오늘 셔먼 맥밀런(Shermon McMillan)을 신임 사장으로 임명했다고 발표했다. 글로벌 포춘 500대 기업에서 성장 전략을 성공적으로 이끌어온 그는 향후 마이크로밴의 전략, 운영, 혁신 파이프라인을 이끌어 지속 가능한 성장을 추진할 예정이다. 마이크로밴의 모회사 바 브랜즈 인터내셔널(Barr Brands International)의 스콧 빌(Scott Beal) 최고경영자(CEO)는 "셔먼 맥밀런은 마이크로밴의 목표를 정확히 이해하고 이를 실현할 수 있는 전략적이고 노련한 리더"라며 "그의 리더십 아래 마이크로밴 브랜드가 한층 강화되고, 글로벌 시장에서의 선도적 위치를 유지할 것이라 확신한다"라고 말했다. 사장으로서 맥밀런은 마이크로밴 브랜드 구축 및 제품 보호 분야에서 가장 신뢰받는 브랜드로 회사의 명성을 높이는 데 주력할 예정이다. 그는 고객 중심, 혁신 실행의 우선순위화, 브랜드 자산
- 김갑성 기자
- 2025-10-16 20:16
-
Microban International Appoints Shermon McMillan as New P…
HUNTERSVILLE, N.C., Oct. 16, 2025 -- Microban International, the global leader in antimicrobial and odor control solutions, today announced the appointment of Shermon McMillan as its new president. A seasoned global executive with a proven record of driving growth at Fortune 500 companies, McMillan will guide Microban strategy, operations and innovation pipeline toward sustainable growth. "Shermon McMillan is a strategic and experienced leader who understands Microban's goals and how to bring them to fruition," said Scott Beal, CEO at Barr Brands International
- 김갑성 기자
- 2025-10-16 20:16
-
Avathon Launches Autonomy for Aerospace Operations
[ 메디채널 김갑성 기자 ] Autonomy has moved beyond the cockpit to the factory floor, the hangar, and the supply chain—transforming Aerospace Operations PLEASANTON, Calif., Oct. 16, 2025 -- Avathon today announced the launch of Autonomy for Aerospace Operations, a unified AI and knowledge platform that connects manufacturing, supply chain, and maintenance data to drive coordinated decision-making across the aerospace lifecycle. By integrating insights from production quality, Bill of Materials (BOM), supplier sourcing, parts availability, and workforce capacity, the platform ena
- 김갑성 기자
- 2025-10-16 19:00
-
NUH And NUS Launch New Molecular Imaging And Theranos…
Powered by Singapore's first next-generation total-body PET/CT system, the new facility aims to transform diagnostics, treatment and research in cancer and beyond SINGAPORE, Oct. 16, 2025 -- The National University Hospital (NUH) and the National University of Singapore (NUS) Clinical Imaging Research Centre (CIRC) have jointly launched the Molecular Imaging and Theranostic Centre, a novel integrated clinical, education, research & development facility that brings together advanced diagnostics, targeted therapy and pioneering research. This landmark development is set
- 김갑성 기자
- 2025-10-16 17:55
-
MOEA DoIT Showcases 65 Cutting-Edge Technologies at TIE
[ 메디채널 김갑성 기자 ] Unveiling AI Clothing Sorting System and New Equipment for Depression Treatment TAIPEI, Oct. 16, 2025 -- The Department of Industrial Technology (DoIT) of the Ministry of Economic Affairs (MOEA) today (16th) joins forces with 12 research institutes and industry partners at the Innovation Economy Pavilion of the Taiwan Innotech Expo (TIE) to showcase 65 innovative technologies spanning smart manufacturing, net zero sustainability, and healthcare. Powered by ITRI's Digital Twin Interactive Performing Technology—the same innovation behind the Life Theater
- 김갑성 기자
- 2025-10-16 17:46
-
SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhan…
BOSTON and ROLLE, Switzerland, Oct. 16, 2025 -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in AI-driven precision medicine, today announced the launch of SOPHiA DDM™ Digital Twins, a breakthrough research technology that creates dynamic, virtual representations of individual patients to simulate potential outcomes and help oncologists make better treatment decisions. SOPHiA DDM™ Digital Twins uses each patient's unique clinical, biological, imaging, and genomic data to generate a computational replica of the patient and their individual disease. Oncologists can use the virtual
- 김갑성 기자
- 2025-10-16 16:01
-
HARMONi-6 Phase III Study of Ivonescimab Accepted by The L…
HONG KONG, Oct. 16, 2025 -- Akeso Inc. (9926.HK) today announced that the groundbreaking results from the registrational Phase III AK112-306/HARMONi-6 study of ivonescimab have been accepted for publication in The Lancet. The study evaluated ivonescimab, a first-in-class PD-1/VEGF bispecific antibody, combined with chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small cell lung cancer (sq-NSCLC). The article of Lancet will be simultaneously published during the 2025 European Society for Medical Oncology (2025 ESMO) Congress. The HARM
- 김갑성 기자
- 2025-10-16 12:15
-
Illumina fuels multiomic discovery with launch of 5-base solu…
At ASHG, an early access customer from the London Health Sciences Center Research Institute demonstrated the power of the 5-base genome for accelerating resolution of rare disease cases Proprietary 5-base chemistry and novel DRAGEN algorithms enable dual-omic inquiry, providing researchers with new tool for precision medicine breakthroughs SAN DIEGO, Oct. 16, 2025 -- Illumina, Inc. (NASDAQ: ILMN) announced the release of its novel 5-base solution, enabling researchers to pursue broader biological questions with accuracy and ease. The 5-base solution marks a major advan
- 김갑성 기자
- 2025-10-16 11:43
-
ROSTI partners with IDC to bring innovative medical device des…
SHANGHAI, Oct. 16, 2025 -- A report from Ringiertrade. MedTec China 2025, which took place at the Shanghai World Expo Exhibition & Convention Center (SWEECC) from September 24-26, served as the ideal platform to promote the latest innovations in the production of medical devices. At this exhibition, ROSTI Integrated Manufacturing Solutions (Suzhou) Co., Ltd. (ROSTI) provided visitors with interesting glimpse of its medical device design, assembly and production solutions aimed at the highly dynamic Asian markets. ROSTI, a pioneer injection molding and assembly for the medic
- 김갑성 기자
- 2025-10-16 11:30
-
Gene Solutions Brings Insights on Advances in MRD and Mu…
SINGAPORE, Oct. 15, 2025 -- What if cancer care could move from reactive to proactive? At the Singapore Society of Oncology Annual Scientific Meeting 2025 (SSO ASM 2025), Gene Solutions showcased how Molecular Residual Disease (MRD) and AI-powered multi-omics technologies are advancing precision oncology across Asia-Pacific, reinforcing Singapore's role as a hub for innovation and global collaboration. The symposium, "Advancing Precision Oncology: MRD and Multi-Omics in Solid Tumors," gathered leading oncologists and molecular biology experts to explore how ctDNA-MRD and mult
- 김갑성 기자
- 2025-10-16 10:30
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-12-12_FRI
- ADSFF Mobilises Capital, Policy and Innovation to Drive the Next Era of Sustainability 02:42
- His Excellency affirmed that NDF has achieved significant international development milestones over the past fifty years, including more than USD 40 billion in assistance 01:35
- ZOWIE Elevates Esports Performance at Budapest Major 2025 01:00
- TraceLink Supports UNICEF's Traceability and Verification System (TRVST) to Advance Safe, Authentic Medicine Access Globally 00:21
- ACE Shutters Notorious Piracy Operations in India 00:01
- Suvoda IRT named a Leader in Everest Group's RTSM PEAK Matrix® 00:00
- Gravity Launches Hybrid Casual Game 'Ragnarok Monster Kitchen' Worldwide! 00:00
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 12월 12일 04시 20분